Insmed (INSM) Change in Inventory (2018 - 2026)
Insmed (INSM) posted quarterly Change in Inventory of $1.9 million for Q1 2026, up 84.72% year-over-year from $1.0 million in Q1 2025, and down 83.97% quarter-over-quarter from $11.8 million in Q4 2025.
Insmed (INSM) Change in Inventory (2018 - 2026) Analysis & Trends
Insmed's Change in Inventory history runs 9 years deep, the most recent figure standing at $1.9 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 84.72% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $32.4 million (up 85.4% YoY), while the FY2025 annual figure was $31.5 million, up 84.93% from the prior year.
- Change in Inventory for Q1 2026 stood at $1.9 million, down from $11.8 million in the prior quarter.
- The five-year high for Change in Inventory was $13.8 million in Q3 2025, with the low at -$2.2 million in Q1 2022.
- The 5-year median for Change in Inventory is $2.1 million (2024), against an average of $3.9 million.
- The sharpest annual moves came in 2022 and 2023: Change in Inventory slumped 181.34% in 2022, then soared 998.0% in 2023.
- Insmed's Change in Inventory stood at $2.3 million in 2022, then jumped by 89.65% to $4.4 million in 2023, then slumped by 52.14% to $2.1 million in 2024, then surged by 454.38% to $11.8 million in 2025, then slumped by 83.97% to $1.9 million in 2026.
- Business Quant data shows INSM's Change in Inventory at $1.9 million in Q1 2026, $11.8 million in Q4 2025, and $13.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.97 Mn |
| Jun 30, 2026 | 12.97 Mn |
| Mar 31, 2026 | 1.89 Mn |
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 11.76 Mn |
| Dec 31, 2025 | 11.76 Mn |
| Sep 30, 2025 | 13.76 Mn |
| Sep 30, 2025 | 13.76 Mn |
| Jun 30, 2025 | 4.98 Mn |
| Jun 30, 2025 | 4.98 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 6.57 Mn |
| Sep 30, 2024 | 6.57 Mn |
| Jun 30, 2024 | 7.76 Mn |
| Jun 30, 2024 | 7.76 Mn |
| Mar 31, 2024 | 598,000.00 |
| Mar 31, 2024 | 598,000.00 |